Press
Press releases
- 05/16/2013PharmaMar to present new studies with Yondelis® at ASCO• Two studies that will be presented are especially noteworthy, as Yondelis® was administered as first-line treatment in patients with different types of soft tissue sarcoma. • The ASCO Annual Meeting is one of the world's leading events in cancer research
-
- 04/25/2013Zeltia obtains 17.6 million euro in EBITDA and continues to increase revenues outside Spain- Of total Group revenue in the quarter, 71% are from overseas. - Cash flow continued to improve and Group debt declined.
-
- 03/20/2013GENOMICA DEVELOPS NEW DIAGNOSTIC KITS FOR SOMATIC MUTATIONS THAT ARE DETERMINANT IN ANTI-TUMOUR THERAPIESGENOMICA has laid the groundwork for an R&D and innovation project related to its CLART® CMA (Cancer Mutation Analysis) diagnostic kit and has established an agreement with the Molecular Pathology Department of Hvidovre University Hospital in Copenhagen.
-
- 02/14/2013Innovation, the key to healthcare reform in Germany and SpainGaspar Casal Foundation and PharmaMar organise an event focusing on German and Spanish healthcare
-
PRESS ARCHIVE